57 Results

People

  1. Scordo
    Scordo
  2. Shah
    Shah
  3. Dahi
    Dahi
  4. Perales
    Perales
  5. Palomba
    Palomba
  6. Giralt
    Giralt
  7. Lin
    Lin
  8. Sauter
    Sauter
  9. Devlin
    Devlin
  10. Shouval
    Shouval

Groups

  1. Bone Marrow Transplant (57)
  2. CTCR Scholars (57)
  3. Center for Hematologic Malignancies (57)
  4. Department of Medicine (57)
  5. Hematologic Malignancies, Division of (57)
  6. Lymphoma (57)
  7. Survivorship Research (55)
  8. MSK Grad Students (49)
  9. Master of Science in Clinical and Translational Cancer Research (48)
  10. Biostatistics Service (33)
  1. "Center for Hematologic Malignancies"
  2. "Lymphoma"
  3. "Michael Scordo"
  4. "Meeting abstract"
Formats
  1. Meeting Abstract (57)
Groups
  1. Bone Marrow Transplant (57)
  2. CTCR Scholars (57)
  3. Center for Hematologic Malignancies (57)
  4. Department of Medicine (57)
  5. Hematologic Malignancies, Division of (57)
  6. Lymphoma (57)

More Groups

People
  1. Michael Scordo (57)
  2. Gunjan Shah (51)
  3. Parastoo Dahi (48)
  4. Miguel-Angel Perales (47)
  5. Maria Palomba (46)
  6. Sergio Giralt (38)

More People

Years
  1. 2023 (22)
  2. 2022 (8)
  3. 2021 (4)
  4. 2020 (6)
  5. 2019 (9)
  6. 2018 (3)

More Years

Publications
  1. Blood (37)
  2. Biology of Blood and Marrow Transplantation (8)
  3. Hematological Oncology (4)
  4. Bone Marrow Transplantation (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. Transplantation and Cellular Therapy (2)

More Publications

Publishers
  1. American Society of Hematology (37)
  2. Elsevier Inc. (12)
  3. Wiley Blackwell (4)
  4. Nature Publishing Group (2)
  5. American Society of Clinical Oncology (1)
  6. Springer (1)

Results (57)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma
    Meeting Abstract

    Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy
    Meeting Abstract

    Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Detection of CAR-T cell persistence with digital droplet PCR: Correlation of in vivo expansion with clinical outcomes in a cohort of B-cell lymphoma patients
    Meeting Abstract

    Cassanello, G.; Borsu, L.; Arcila, M. E.; Yao, J.; Boroujeni, A. M.; Ewalt, M.; Patel, U.; Chan, R.; Gray, B.; Luna De Abia, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • From widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T- cell therapy: Less is better
    Meeting Abstract

    Melica, G.; Luna De Abia, A.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Landego, I.; Lin, R. J.; Palomba, M. L.; Parascondola, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of response to systemic bridging therapy on clinical outcomes and cytokine profiles in patients receiving CD19-CAR T-cell therapy for B-cell lymphoma
    Meeting Abstract

    Wills, B.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Parascondola, A.; Saldia, A.; Imber, B. S.; Tomas, A. A.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluation of the impact of tocilizumab use in recipients of CAR T cells for non-Hodgkin lymphoma
    Meeting Abstract

    Cassanello, G.; Luttwak, E.; Devlin, S. M.; Luna De Abia, A.; Corona, M.; Landego, I.; Parascondola, A.; Saldia, A.; Tomas, A. A.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Pilot study of longitudinal geriatric assessment and neurocognitive evaluation in CAR T-cell therapy for older patients with relapsed refractory, large B-cell lymphoma
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Correa, D.; Elko, T. A.; Lobaugh, S.; Baser, R.; Koch, A.; Hanley, D. M.; Palomba, M. L.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save